These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 14025918)

  • 1. [Influence of aldosterone on the intradermal test with angiotensin].
    DE MARTINIS C; FONZO D
    Boll Soc Ital Biol Sper; 1963 Mar; 39():330-2. PubMed ID: 14025918
    [No Abstract]   [Full Text] [Related]  

  • 2. [The intradermal test with angiotensin II and pathogenesis of essential hypertension].
    Policlinico Prat; 1965 Aug; 72(31):1049-51. PubMed ID: 4285054
    [No Abstract]   [Full Text] [Related]  

  • 3. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
    Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K
    Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular synthesis of aldosterone: role in hypertension.
    Takeda Y
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):75-9. PubMed ID: 15134804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
    Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
    J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness and the renin-angiotensin-aldosterone system.
    Mahmud A; Feely J
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
    Hannila-Handelberg T; Kontula K; Tikkanen I; Tikkanen T; Fyhrquist F; Helin K; Fodstad H; Piippo K; Miettinen HE; Virtamo J; Krusius T; Sarna S; Gautschi I; Schild L; Hiltunen TP
    BMC Med Genet; 2005 Jan; 6():4. PubMed ID: 15661075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of shock, considered irreversible, with angiotensin and aldosterone].
    DOMINGUEZ JB; GOMEZ R; PRIETO ME
    Rev Med Chil; 1963 Jan; 91():9-14. PubMed ID: 14028528
    [No Abstract]   [Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects.
    Brown MJ; Coltart J; Gunewardena K; Ritter JM; Auton TR; Glover JF
    Clin Sci (Lond); 2004 Aug; 107(2):167-73. PubMed ID: 15040783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
    Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
    Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.